retatrutide clinical trials phase 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 New 3 results are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of retatrutide clinical trials phase FDA

J Soc Gynecologic Invest

(PubMed) Liebman M, Chai WW, Harvey E, Boenisch L

Liver health: In a human trial involving 85 subjects, participants who received Siliphos saw positive effects on ALT, -glutamyl transpeptidase (an important enzyme found in high levels in the liver), and insulinemia (a state of high insulin in the blood)

Exploiting the semidestructive nature of gas cluster ion beam time-of-flight secondary ion mass spectrometry imaging for simultaneous localization and confident lipid annotations

Research in overweight cats suggests supplementation can enhance metabolic rate and promote fatty acid oxidation (Center SA, 2012)